Cancer evolution is fueled by epigenetic as well as genetic diversity. In chronic lymphocytic leukemia (CLL), intra-tumoral DNA methylation (DNAme) heterogeneity empowers evolution. Here, to comprehensively study the epigenetic dimension of cancer evolution, we integrate DNAme analysis with histone modification mapping and single cell analyses of RNA expression and DNAme in 22 primary CLL and 13 healthy donor B lymphocyte samples. Our data reveal corrupted coherence across different layers of the CLL epigenome. This manifests in decreased mutual information across epigenetic modifications and gene expression attributed to cell-to-cell heterogeneity. Disrupted epigenetic-transcriptional coordination in CLL is also reflected in the dysregulat...
Malignant transformation of cells from the lymphoid lineage can occur at various developmental stage...
Thesis: Ph. D. in Medical Engineering and Medical Physics, Harvard-MIT Program in Health Sciences an...
SummaryThe genetic programs that maintain leukemia stem cell (LSC) self-renewal and oncogenic potent...
Genetic and epigenetic intra-tumoral heterogeneity cooperate to shape the evolutionary course of can...
Although clonal selection by genetic driver aberrations in cancer is well documented, the ability of...
SummaryIntratumoral heterogeneity plays a critical role in tumor evolution. To define the contributi...
In chronic lymphocytic leukemia (CLL), a diverse set of genetic mutations is embedded in a deregulat...
In chronic lymphocytic leukemia (CLL), a diverse set of genetic mutations is embedded in a deregulat...
Most human cancers converge to a deregulated methylome with reduced global levels and elevated methy...
Genome-wide association studies have provided evidence for inherited genetic predisposition to chron...
Chronic lymphocytic leukemia (CLL) is characterized by substantial clinical heterogeneity, despite r...
Intratumoral heterogeneity plays a critical role in tumor evolution. To define the contribution of D...
Intra-tumoral genetic heterogeneity has been characterized across cancers by genome sequencing of bu...
A public repository of data processed for Mallm, Iskar, Ishaque et. al. 2018 Linking aberrant chroma...
BACKGROUND: In cancer, normal epigenetic patterns are disturbed and contribute to gene expression ch...
Malignant transformation of cells from the lymphoid lineage can occur at various developmental stage...
Thesis: Ph. D. in Medical Engineering and Medical Physics, Harvard-MIT Program in Health Sciences an...
SummaryThe genetic programs that maintain leukemia stem cell (LSC) self-renewal and oncogenic potent...
Genetic and epigenetic intra-tumoral heterogeneity cooperate to shape the evolutionary course of can...
Although clonal selection by genetic driver aberrations in cancer is well documented, the ability of...
SummaryIntratumoral heterogeneity plays a critical role in tumor evolution. To define the contributi...
In chronic lymphocytic leukemia (CLL), a diverse set of genetic mutations is embedded in a deregulat...
In chronic lymphocytic leukemia (CLL), a diverse set of genetic mutations is embedded in a deregulat...
Most human cancers converge to a deregulated methylome with reduced global levels and elevated methy...
Genome-wide association studies have provided evidence for inherited genetic predisposition to chron...
Chronic lymphocytic leukemia (CLL) is characterized by substantial clinical heterogeneity, despite r...
Intratumoral heterogeneity plays a critical role in tumor evolution. To define the contribution of D...
Intra-tumoral genetic heterogeneity has been characterized across cancers by genome sequencing of bu...
A public repository of data processed for Mallm, Iskar, Ishaque et. al. 2018 Linking aberrant chroma...
BACKGROUND: In cancer, normal epigenetic patterns are disturbed and contribute to gene expression ch...
Malignant transformation of cells from the lymphoid lineage can occur at various developmental stage...
Thesis: Ph. D. in Medical Engineering and Medical Physics, Harvard-MIT Program in Health Sciences an...
SummaryThe genetic programs that maintain leukemia stem cell (LSC) self-renewal and oncogenic potent...